NASDAQ: VKTX · Biotechnology
Over the past week, Viking Therapeutics (VKTX) drew about 601 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 27% bullish but is at odds: News runs 42% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 18 of 20 analysts rating VKTX a buy.
There is little buzz around VKTX this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 90% buy share sits next to a crowd that ranges from Reddit at 0% to News at 42%. No other tracker puts the two side by side.
20 analysts have weighed in: a Strong Buy consensus: 18 buy calls against 0 sell, with an average 12-month price target of $94.71.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 63 points above the crowd average of 27%, the professionals are more constructive than retail. The split is inside the crowd: News reads 42% bullish while Reddit sits at 0%, a 42-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Viking Therapeutics (VKTX) buzz held moderate around 43.9 while the price drifted down 10.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 8.9M shares. Updated Oct 10, 2026. Over the last 7 trading days, VKTX lost 6.6%. Buzz activity in the recent week averaged 47.5 and was variable, swinging between 34.9 and 58.2. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 21 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for VKTX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live VKTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 11, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (18 / 2 / 0) |
| Crowd bullish (7d) | 27% |
| Avg price target | $94.71 |
| Most bullish source | News, 42% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 42 pts |
| Mentions (7d) | 601 |
| Market cap | $3.53B |
| EPS · Beta | -$4.67 · 0.6 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Viking Therapeutics (VKTX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 27% bullish across 3 active sources. Those sources contribute 601 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Viking Therapeutics (VKTX) is fairly quiet with 5 mentions over the last 7 days; the 30-day context spans 13 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Viking Therapeutics (VKTX), averaging 27% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 42% bullish and Reddit at 0%, a 42-point spread. On the professional side, 18 of 20 analysts rate VKTX a buy.
Of the 20 analysts covering Viking Therapeutics (VKTX), 18 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $94.71. That puts the street ahead of the crowd, which averages 27% bullish.
Viking Therapeutics (VKTX)'s cross-source average is bearish at 27% bullish. All 3 tracked sources lean bearish. X reads 38% bullish, News reads 42% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Viking Therapeutics (VKTX) at 27% bullish. All 3 tracked sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is rising across News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 584 mentions (97% of total volume). News contributes 12 mentions and Reddit contributes 5 mentions. The cross-source average is bearish at 27% bullish, while news is the only source with rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. VKTX's sell signal at 93/100 conviction reflects a bearish cross-source average at 27% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The VKTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key